Fact CheckerSign in

NCT06800768Recruiting

The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery

Source: ClinicalTrials.gov · Last updated 30 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to investigate the value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery.

Status (registry)
Recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
24 Jan 2025
Start date
1 Feb 2025
Primary completion date
31 Jan 2030
Lead sponsor
Ruijin Hospital
NCT number
NCT06800768

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 1 Feb 2025 to the primary completion date, 31 Jan 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc.
  • Intestinal perforation, complete intestinal obstruction.

Other

  • Pregnant women and women who may be pregnant, women who are breastfeeding.
  • Non-compliant person.

Who the study is looking for

  • Patients with thyroid cancer who have undergone surgery and are suspected of recurrence or metastasis during clinical evaluation.
  • Signed and dated informed consent form.
  • Commitment to comply with research procedures and co-operation in the implementation of the full research process.
  • Aged 18-80 years old.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.